Fresenius Medical Care AG/ DE0005785802 /
| 11/8/2024 5:20:03 PM | Chg. +0.63 | Volume | Bid10/2/2024 | Ask9/12/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 39.80EUR | +1.60% | 570 Turnover: 22,661.18 |
-Bid Size: - | -Ask Size: - | 11.67 bill.EUR | 2.99% | 23.40 |
Assets
| 2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 3,836 | 4,190.3000 | 4,056.9000 | 4,235 | 4,152.7000 | ||||||
| Intangible Assets | 681.3000 | 1,426.3000 | 1,381 | 1,459.4000 | 1,518.7000 | ||||||
| Long-Term Investments | 649.8000 | 696.9000 | 761.1000 | 786.9000 | 773.7000 | ||||||
| Fixed Assets | - | - | - | - | 27,550.7000 | ||||||
| Inventories | 1,466.8000 | 1,663.3000 | 1,895.3000 | 2,038 | 2,296.2000 | ||||||
| Accounts Receivable | 3,337.7000 | 3,421.3000 | 3,153 | 3,409.1000 | 3,714.3000 | ||||||
| Cash and Cash Equivalents | 2,145.6000 | 1,007.7000 | 1,081.5000 | 1,481.7000 | 1,273.8000 | ||||||
| Current Assets | 7,846.9000 | 7,165.1000 | 7,275.3000 | 7,967.2000 | 8,203.5000 | ||||||
| Total Assets | 26,242.3000 | 32,934.7000 | 31,689 | 34,366.6000 | 35,754.1000 | ||||||
Liabilities
| 2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 641.3000 | 716.5000 | 732 | 736.1000 | 931.3000 | ||||||
| Long-term debt | - | - | - | - | 11,175.7000 | ||||||
| Liabilities to Banks | 1,205.3000 | 1,150 | 63 | 1,178.4000 | - | ||||||
| Provisions | 626.5000 | 739.7000 | 785.9000 | 868.5000 | 5,475.5000 | ||||||
| Liabilities | 14,483.9000 | 19,707.5000 | 19,357.7000 | 20,387.5000 | 20,304.9000 | ||||||
| Share Capital | 307.8790 | 304.4370 | 292.8770 | 293.0040 | - | ||||||
| Total Equity | 11,758.4000 | 11,957.9000 | 11,215.1000 | 12,698.8000 | 15,449.2000 | ||||||
| Minority Interests | - | 1,269.3000 | 1,116.2000 | 1,280.3000 | 1,459.7000 | ||||||
| Total liabilities equity | 26,242.3000 | 32,934.7000 | 31,689 | 34,366.6000 | 35,754.1000 | ||||||
Income Statement
| 2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 16,546.9000 | 17,476.6000 | 17,859.1000 | 17,618.7000 | 19,398 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 3,037.8000 | 2,269.6000 | 2,304.4000 | 1,852.3000 | 1,511.8000 | ||||||
| Interest Income | -301.1000 | -429.5000 | -368 | -280.4000 | -292.4000 | ||||||
| Income Before Taxes | 2,736.7000 | 1,840.1000 | 1,936.4000 | 1,571.9000 | 1,219.3000 | ||||||
| Income Taxes | 511.1000 | 401.6000 | 500.6000 | 352.8000 | 325 | ||||||
| Minority Interests Profit | -243.7000 | -238.9000 | -271.5000 | -249.7000 | -220.9000 | ||||||
| Net Income | 1,981.9000 | 1,199.6000 | 1,164.4000 | 969.3000 | 673.4000 | ||||||
Per Share
Cash Flow
| 2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 2,061.9000 | 2,567 | 4,233.2000 | 2,489.5000 | 2,167.4000 | ||||||
| Cash Flow from Investing Activities | -245 | -3,286 | -1,334.9000 | -1,196.2000 | -734.7000 | ||||||
| Cash Flow from Financing | -681.7000 | -466.6000 | -2,664 | -1,024.4000 | -1,617.4000 | ||||||
| Decrease / Increase in Cash | 1,167.5000 | -1,137.9000 | 73.8000 | 400.1000 | - | ||||||
| Employees | 112,658 | 120,659 | 125,364 | 122,909 | 128,044 | ||||||
